ALKEM LABORATORIES LIMITED

Alkem Laboratories Ltd (BOM:539523) Q4 2026 Earnings Call Highlights: Record Profitability and ...

India Opened the Floodgates on Weight-Loss Generics

Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India

Esperion Therapeutics Inc (ESPR) Strengthens Business Outlook Amid Strategic Agreements

Axsome Therapeutics (AXSM) Valuation After SUNOSI Patent Settlement Extends Generic Entry Timeline